Shadow Regulation

LegitScript’s Influence: More Harm Than Good?

Brian Rogers0176 views

LegitScript, a private company with significant control over major tech and payment companies, influences what medications Americans can access and purchase online. This control supports big pharmaceutical companies by blocking affordable Indian generics, maintaining high drug prices. This article argues that such overreach undermines public health and calls for greater transparency and legislative intervention to ensure Americans have access to safe and affordable medications.

Read more

How Big Pharma, the FDA, Congress, and Shadow Organizations Violate Our Constitutional Rights to Healthcare

Brian Rogers0137 views

The American healthcare system is often lauded as one of the most advanced in the world, but beneath the surface lies a troubling reality of collusion involving Big Pharma, the FDA, Congress, and shadow organizations like LegitScript. These entities, created to protect public health, prioritize corporate profits over individual rights and access to affordable healthcare. This article exposes how these powerful groups manipulate regulations, lobby against public interests, and violate our constitutional rights to make healthcare choices. Through financial power, regulatory influence, and digital censorship, they maintain high drug prices and limit access to affordable medications. Reform is urgently needed to ensure transparency, accountability, and a healthcare system that serves the needs of the people.

Read more

Shadow Pharmacy Regulation and Market Monopoly: The Case of LegitScript and PharmacyChecker

Brian Rogers0370 views

In the shadowy corridors where policy meets business, the conflict between PharmacyChecker and LegitScript underscores the struggle over who controls access to affordable healthcare in the U.S. LegitScript’s influential role in online pharmacy vetting, impacting major corporations like Google and Visa, highlights its significant, albeit unofficial, regulatory power. PharmacyChecker’s antitrust lawsuit challenges this control, alleging unfair market practices by LegitScript to monopolize online pharmacy information. This case could redefine the future of medication access in the U.S., drawing global attention to models like Ashvin Medicara, which promotes transparency and patient access over corporate dominance. The outcome will be pivotal for healthcare accessibility and the balance of consumer rights against corporate influence.

Read more